| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetic acid is elevated in the exhaled breath of cystic fibrosis patients
|
Španěl, Patrik
|
|
2017
|
16 |
5 |
p. e17-e18
nvt p.
|
artikel
|
| 2 |
A first step to STOP cystic fibrosis exacerbations
|
Burgel, Pierre-Régis
|
|
2017
|
16 |
5 |
p. 529-531
3 p.
|
artikel
|
| 3 |
Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children
|
Garg, Millie
|
|
2017
|
16 |
5 |
p. 631-636
6 p.
|
artikel
|
| 4 |
A multiple reader scoring system for Nasal Potential Difference parameters
|
Solomon, George M.
|
|
2017
|
16 |
5 |
p. 573-578
6 p.
|
artikel
|
| 5 |
Biobanking: towards increased access of biomaterials in cystic fibrosis. Report on the pre-conference meeting to the 13th ECFS Basic Science Conference, Pisa, 30 March-2 April, 2016
|
Beekman, Jeffrey M.
|
|
2017
|
16 |
5 |
p. 616-621
6 p.
|
artikel
|
| 6 |
Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
|
Inman, T.B.
|
|
2017
|
16 |
5 |
p. 628-630
3 p.
|
artikel
|
| 7 |
Development and validation of CF-Medication Beliefs Questionnaire: A mixed-methods approach
|
Eakin, Michelle N.
|
|
2017
|
16 |
5 |
p. 637-644
8 p.
|
artikel
|
| 8 |
Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?
|
Nightingale, Julia Anne
|
|
2017
|
16 |
5 |
p. 585-591
7 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2017
|
16 |
5 |
p. ii-
1 p.
|
artikel
|
| 10 |
High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis
|
Cavalli, Zoé
|
|
2017
|
16 |
5 |
p. 579-584
6 p.
|
artikel
|
| 11 |
Interpretation of Cystic Fibrosis Centre rankings: Meaningful comparisons or biased statistics?
|
Stanojevic, Sanja
|
|
2017
|
16 |
5 |
p. 534-535
2 p.
|
artikel
|
| 12 |
Investigating the variation in the incidence of new Pseudomonas aeruginosa infection between paediatric cystic fibrosis centres
|
Gilchrist, F.J.
|
|
2017
|
16 |
5 |
p. e14-e16
nvt p.
|
artikel
|
| 13 |
Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension
|
Witters, Peter
|
|
2017
|
16 |
5 |
p. e11-e13
nvt p.
|
artikel
|
| 14 |
News
|
|
|
2017
|
16 |
5 |
p. 536-537
2 p.
|
artikel
|
| 15 |
Peripheral muscle abnormalities in cystic fibrosis: Etiology, clinical implications and response to therapeutic interventions
|
Gruet, Mathieu
|
|
2017
|
16 |
5 |
p. 538-552
15 p.
|
artikel
|
| 16 |
Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug
|
Gunasekara, Lasantha
|
|
2017
|
16 |
5 |
p. 565-572
8 p.
|
artikel
|
| 17 |
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
|
VanDevanter, D.R.
|
|
2017
|
16 |
5 |
p. 607-615
9 p.
|
artikel
|
| 18 |
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations
|
Sanders, Don B.
|
|
2017
|
16 |
5 |
p. 592-599
8 p.
|
artikel
|
| 19 |
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations
|
West, Natalie E.
|
|
2017
|
16 |
5 |
p. 600-606
7 p.
|
artikel
|
| 20 |
Take it to the Bank
|
Clancy, J.P.
|
|
2017
|
16 |
5 |
p. 532-533
2 p.
|
artikel
|
| 21 |
The AREST CF experience in biobanking — More than just tissues, tubes and time
|
Garratt, Luke W.
|
|
2017
|
16 |
5 |
p. 622-627
6 p.
|
artikel
|
| 22 |
The evolution of lung transplantation for cystic fibrosis: A 2017 update
|
Snell, Gregory
|
|
2017
|
16 |
5 |
p. 553-564
12 p.
|
artikel
|
Tijdschrift beschrijving